Related Experiment Videos
AZT causes tissue-specific inhibition of mitochondrial bioenergetic function
1Tufts University, Department of Biology, Medford, MA 02155.
Biochemical and Biophysical Research Communications
|July 15, 1993
Summary
Long-term AZT therapy for AIDS causes mitochondrial myopathy. AZT inhibits mitochondrial respiration, particularly complex I, and affects succinate transport in a tissue-specific manner, explaining toxicity.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Mitochondrial myopathy is a key limitation of zidovudine (AZT) in AIDS treatment.
- Understanding AZT's biochemical effects on mitochondria is crucial for its clinical application.
Purpose of the Study:
- To investigate the biochemical basis of AZT-induced mitochondrial myopathy.
- To determine the tissue-specific effects of AZT on mitochondrial bioenergetics.
Main Methods:
- Isolated mitochondria from rat skeletal muscle, brain, and liver were used.
- Assessed the impact of AZT on NADH-linked and succinate-linked respiration.
- Measured NADH-cytochrome c reductase and succinate-cytochrome c reductase activities.
Main Results:
- AZT inhibited NADH-linked respiration and NADH-cytochrome c reductase activity in all tested tissues.
- High AZT concentrations block electron transfer at respiratory complex I.
- AZT caused tissue-specific inhibition of succinate-linked respiration, possibly via succinate transport disruption.
Conclusions:
- AZT's mitochondrial toxicity mechanism involves complex I inhibition and potential succinate transport interference.
- These findings explain tissue-specific mitochondrial damage in patients on long-term AZT.
- AZT's antiviral activity might be separate from its mitochondrial toxicity.